business

Ipca Laboratories expects to clock 18-20% growth in FY12

AK Jain, ED, Ipca Laboratories in an interview with CNBC-TV18 said that the company has projected normal growth of around 18-20% for the whole year. But if it receives the much awaited USFDA approval then it can register much higher growth ahead.

first published: May 25, 2011 01:26 pm